Journal of Nutrition

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supporting Material
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Gallo, D.
Right arrow Articles by Scambia, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gallo, D.
Right arrow Articles by Scambia, G.
© 2008 American Society for Nutrition J. Nutr. 138:1360-1364, July 2008


Nutrition and Disease

Soy Phytochemicals Decrease Nonsmall Cell Lung Cancer Growth In Female Athymic Mice1–3,

Daniela Gallo4, Gian Franco Zannoni5, Ilaria De Stefano4, Marco Mosca4, Cristiano Ferlini4, Elisabetta Mantuano4 and Giovanni Scambia4,*

4 Department of Obstetrics and Gynecology and 5 Department of Histopathology, Catholic University of the Sacred Heart, 00168 Rome, Italy

* To whom correspondence should be addressed. E-mail: giovanni.scambia{at}rm.unicatt.it.

This study investigated the effects of a phytoestrogen-containing standardized soy extract (SSE) on the growth of nonsmall cell lung cancer (NSCLC; A549) xenografts in female athymic mice. Tumor-bearing mice received either sterile water or SSE [50 or 100 mg/(kg·d), per os], 5 d/wk, until the mean tumor weight in each group was at least 900 mg. Treatment with SSE reduced tumor growth in the high-dose group compared with control (P < 0.01); tumors in both treated groups had reduced proliferation and greater apoptosis compared with controls (P < 0.05). SSE treatment also induced diffuse central necrosis, reducing the viable tissue mass within the tumor. Whereas tumor levels of epidermal growth factor receptor were comparable in control and treated mice, the expression of phosphorylated protein kinase B (p-Akt) was lower in tumors of mice treated with 100 mg SSE/(kg·d) than in controls (P < 0.01). The protein level of phosphorylated mitogen-activated protein kinase also tended to be lower (P = 0.07) in this group than in controls. Estrogen receptor (ER){alpha} and ERβ were present in tumors, but their expression levels did not differ among groups. Serum insulin-like growth factor-1 concentrations also were not affected by the treatments. In conclusion, we found that soy phytochemicals slow the in vivo growth of NSCLC xenografts; the modulation of the Akt-signaling pathway observed in tumors of SSE-treated mice may have a role in the activity observed. Our research provides further support for the concept that consumption of phytoestrogens may be effective in delaying lung cancer progression.








Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]